Objectives: The aim of this study was to assess the efficacy and safety of low doses of diclofenac sodium (DCF) in attaining normothermia with minimal major side effects in patients with acute cerebral damage. The study was designed to verify the adequate, prolonged antipyretic action of DCF infusion, to quantify its haemodynamic and cerebral impact and to assess any negative effect on renal and liver function. Design: Retrospective, cohort study on prospectively collected data. Setting: Intensive care unit (ICU) of a university hospital. Patient population: Five patients with subarachnoid haemorrhage and seven severe head-trauma victims with febrile illness of various infectious origin. Interventions: Continuous i.v. infusion of a low dose (0.04 mg/kg/h) of DCF for 48 h. Measurements and results: Systemic and cerebral haemodynamic data were collected at 4 h intervals for 8 h before diclofenac infusion and 48 h after. Renal and liver functions were monitored. Normothermia, defined as external temperature < 37.5 degrees Celsius (°C), was achieved in all cases. Intracranial pressure was significantly lowered and mean arterial pressure was unaffected, so cerebral perfusion pressure rose after DCF. Hepatic and renal function were not altered in the 48 h post DCF. Mean urinary output was preserved at high flow and was not influenced by DCF. Conclusions: Continuous infusion of low-dose DCF attained normothermia without any major cerebral or systemic side effects. Renal and liver functions were unaffected. Once normothermia was achieved, intracranial and cerebral perfusion pressure improved.

Cormio, M., Citerio, G., Spear, S., Fumagalli, R., Pesenti, A. (2000). Control of fever by continuous, low-dose diclofenac sodium infusion in acute cerebral damage patients. INTENSIVE CARE MEDICINE, 26(5), 552-557 [10.1007/s001340051203].

Control of fever by continuous, low-dose diclofenac sodium infusion in acute cerebral damage patients

CORMIO, MANUELA
Primo
;
CITERIO, GIUSEPPE
Secondo
;
FUMAGALLI, ROBERTO
Penultimo
;
PESENTI, ANTONIO MARIA
Ultimo
2000

Abstract

Objectives: The aim of this study was to assess the efficacy and safety of low doses of diclofenac sodium (DCF) in attaining normothermia with minimal major side effects in patients with acute cerebral damage. The study was designed to verify the adequate, prolonged antipyretic action of DCF infusion, to quantify its haemodynamic and cerebral impact and to assess any negative effect on renal and liver function. Design: Retrospective, cohort study on prospectively collected data. Setting: Intensive care unit (ICU) of a university hospital. Patient population: Five patients with subarachnoid haemorrhage and seven severe head-trauma victims with febrile illness of various infectious origin. Interventions: Continuous i.v. infusion of a low dose (0.04 mg/kg/h) of DCF for 48 h. Measurements and results: Systemic and cerebral haemodynamic data were collected at 4 h intervals for 8 h before diclofenac infusion and 48 h after. Renal and liver functions were monitored. Normothermia, defined as external temperature < 37.5 degrees Celsius (°C), was achieved in all cases. Intracranial pressure was significantly lowered and mean arterial pressure was unaffected, so cerebral perfusion pressure rose after DCF. Hepatic and renal function were not altered in the 48 h post DCF. Mean urinary output was preserved at high flow and was not influenced by DCF. Conclusions: Continuous infusion of low-dose DCF attained normothermia without any major cerebral or systemic side effects. Renal and liver functions were unaffected. Once normothermia was achieved, intracranial and cerebral perfusion pressure improved.
Articolo in rivista - Articolo scientifico
Cerebral perfusion pressure; Diclofenac sodium; Fever; Head trauma; Intracranial pressure; Subarachnoid haemorrhage;
English
2000
26
5
552
557
reserved
Cormio, M., Citerio, G., Spear, S., Fumagalli, R., Pesenti, A. (2000). Control of fever by continuous, low-dose diclofenac sodium infusion in acute cerebral damage patients. INTENSIVE CARE MEDICINE, 26(5), 552-557 [10.1007/s001340051203].
File in questo prodotto:
File Dimensione Formato  
Intensive Care Med 2000 Cormio.pdf

Solo gestori archivio

Dimensione 136.86 kB
Formato Adobe PDF
136.86 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/55297
Citazioni
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 31
Social impact